Search research articles
Contact Us
Filters
Showing results (211-220 of 219) with videos related to
Page
of 22
Sort By:
You have reached the last page of results.
This site can display upto 219 results.
Gastroenterology
|
January 24, 2018
Ceragenin CSA13 Reduces Clostridium difficile Infection in Mice by Modulating the Intestinal Microbiome and Metabolites
Jiani Wang, Sally Ghali, Chunlan Xu, et al.
Targeted Oncology
|
July 1, 2021
Phase I Study and Pilot Efficacy Analysis of Entinostat, a Novel Histone Deacetylase Inhibitor, in Chinese Postmenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer
Jiani Wang, Qingyuan Zhang, Qiao Li, et al.
Brain Research Bulletin
|
February 25, 2026
Glucose metabolism drives the hierarchical propagation of gray matter atrophy from the orbitofrontal cortex in obesity
Weihua Li, Zhirong Miao, Chifa Ma, et al.
Breast (Edinburgh, Scotland)
|
November 1, 2025
Associations between dynamic hematological indicators and outcomes in HR-positive, HER2-negative metastatic breast cancer treated with bireociclib or placebo plus fulvestrant: Findings from the BRIGHT-2 trial
Hangcheng Xu, Yan Wang, Qiang Sa, et al.
Journal of Korean Medical Science
|
February 3, 2011
The correlation between thyrotropin and dyslipidemia in a population-based study
Li Lu, Beibei Wang, Zhongyan Shan, et al.
Scientific Reports
|
November 29, 2017
CSA13 inhibits colitis-associated intestinal fibrosis via a formyl peptide receptor like-1 mediated HMG-CoA reductase pathway
Chunlan Xu, Sally Ghali, Jiani Wang, et al.
Endocrine Journal
|
December 8, 2010
The relationship between serum thyrotropin and components of metabolic syndrome
Yaxin Lai, Jiani Wang, Fengwei Jiang, et al.
International Journal of Cancer
|
August 16, 2025
A multicenter randomized controlled trial of intrapleural perfusion of methotrexate-loaded tumor cell-derived microparticles combined with systemic therapy for malignant pleural effusion
Cheng Zeng, Yujing Tan, Zhimin Jiao, et al.
Acta Pharmaceutica Sinica. B
|
May 30, 2023
Entinostat, a class I selective histone deacetylase inhibitor, plus exemestane for Chinese patients with hormone receptor-positive advanced breast cancer: A multicenter, randomized, double-blind, placebo-controlled, phase 3 trial
Binghe Xu, Qingyuan Zhang, Xichun Hu, et al.
Page
of 22
Search research articles
Search
Showing results (211-220 of 219) with videos related to
Sort By:
Page
of 22
You have reached the last page of results.
This site can display upto 219 results.
Gastroenterology
|
January 24, 2018
Ceragenin CSA13 Reduces Clostridium difficile Infection in Mice by Modulating the Intestinal Microbiome and Metabolites
Jiani Wang, Sally Ghali, Chunlan Xu, et al.
Targeted Oncology
|
July 1, 2021
Phase I Study and Pilot Efficacy Analysis of Entinostat, a Novel Histone Deacetylase Inhibitor, in Chinese Postmenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer
Jiani Wang, Qingyuan Zhang, Qiao Li, et al.
Brain Research Bulletin
|
February 25, 2026
Glucose metabolism drives the hierarchical propagation of gray matter atrophy from the orbitofrontal cortex in obesity
Weihua Li, Zhirong Miao, Chifa Ma, et al.
Breast (Edinburgh, Scotland)
|
November 1, 2025
Associations between dynamic hematological indicators and outcomes in HR-positive, HER2-negative metastatic breast cancer treated with bireociclib or placebo plus fulvestrant: Findings from the BRIGHT-2 trial
Hangcheng Xu, Yan Wang, Qiang Sa, et al.
Journal of Korean Medical Science
|
February 3, 2011
The correlation between thyrotropin and dyslipidemia in a population-based study
Li Lu, Beibei Wang, Zhongyan Shan, et al.
Scientific Reports
|
November 29, 2017
CSA13 inhibits colitis-associated intestinal fibrosis via a formyl peptide receptor like-1 mediated HMG-CoA reductase pathway
Chunlan Xu, Sally Ghali, Jiani Wang, et al.
Endocrine Journal
|
December 8, 2010
The relationship between serum thyrotropin and components of metabolic syndrome
Yaxin Lai, Jiani Wang, Fengwei Jiang, et al.
International Journal of Cancer
|
August 16, 2025
A multicenter randomized controlled trial of intrapleural perfusion of methotrexate-loaded tumor cell-derived microparticles combined with systemic therapy for malignant pleural effusion
Cheng Zeng, Yujing Tan, Zhimin Jiao, et al.
Acta Pharmaceutica Sinica. B
|
May 30, 2023
Entinostat, a class I selective histone deacetylase inhibitor, plus exemestane for Chinese patients with hormone receptor-positive advanced breast cancer: A multicenter, randomized, double-blind, placebo-controlled, phase 3 trial
Binghe Xu, Qingyuan Zhang, Xichun Hu, et al.
Page
of 22